An Entity of Type: animal, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Nancy A. Thornberry is the founding CEO and current Chair, R&D at Kallyope Inc. in New York City. She previously worked with Merck Research Laboratories (MRL), joining the company in 1979 as a biochemist and retiring from the position of Senior Vice President and Franchise Head, Diabetes and Endocrinology in 2013.

Property Value
dbo:abstract
  • Nancy A. Thornberry is the founding CEO and current Chair, R&D at Kallyope Inc. in New York City. She previously worked with Merck Research Laboratories (MRL), joining the company in 1979 as a biochemist and retiring from the position of Senior Vice President and Franchise Head, Diabetes and Endocrinology in 2013. In 1992, Thornberry identified the first caspase, Caspase-1/Interleukin-1 converting enzyme (ICE). In 1999, Thornberry initiated Merck's research into dipeptidyl peptidase-4, leading to the development of FDA-approved treatments for Type 2 diabetes. She has received a number of awards, including the 2011 PhRMA Discoverer’s Award. (en)
dbo:almaMater
dbo:nationality
dbo:residence
dbo:thumbnail
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 55519401 (xsd:integer)
dbo:wikiPageLength
  • 16689 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1113837847 (xsd:integer)
dbo:wikiPageWikiLink
dbp:align
  • right (en)
dbp:almaMater
dbp:awards
  • 2011 (xsd:integer)
dbp:caption
  • Nancy Thornberry, 2017 (en)
dbp:field
  • Metabolic disorders, Drug discovery (en)
dbp:name
  • Nancy Ann Thornberry (en)
dbp:nationality
dbp:residence
dbp:video
  • “Bench to bedside -- discovery of JANUVIA (Sitagliptin)”, Ann Weber & Nancy Thornberry, TEDxNJIT (en)
  • “PhRMA11 Discoverers Award Winner 2011”, PhRMAPress (en)
dbp:width
  • 210 (xsd:integer)
dbp:wikiPageUsesTemplate
dbp:workInstitutions
  • Kallyope Inc., Merck Research Laboratories (en)
dcterms:subject
rdf:type
rdfs:comment
  • Nancy A. Thornberry is the founding CEO and current Chair, R&D at Kallyope Inc. in New York City. She previously worked with Merck Research Laboratories (MRL), joining the company in 1979 as a biochemist and retiring from the position of Senior Vice President and Franchise Head, Diabetes and Endocrinology in 2013. (en)
rdfs:label
  • Nancy Thornberry (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
foaf:name
  • Nancy Ann Thornberry (en)
is dbo:wikiPageDisambiguates of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License